What is the price-to-earnings ratio of Integragen?
The price-earnings ratio of Integragen is currently -1.76.
Integragen P/E 2025
Integragen P/E
-1.76
Ticker
ALINT.PA
ISIN
FR0010908723
WKN
A1J1JV
As of Jan 6, 2025, Integragen's P/E ratio was -1.76, a -100.23% change from the 774.21 P/E ratio recorded in the previous year.
The Integragen P/E history
Integragen Aktienanalyse
What does Integragen do?
IntegraGen SA is a French biotechnology company based in Evry. It was founded in 2000 and is one of the leading companies in developing commercial applications in genomics and biology. The business model of IntegraGen SA consists of providing solutions and services for the diagnosis and treatment of various diseases, such as cancer, neurodegenerative diseases, and other genetically related diseases. The company is divided into two main areas: Diagnostics and Genomics. The Diagnostics area offers a wide range of services to its customers, including an oncology platform for the diagnosis and prediction of cancer using exclusive biomarker sets. Other diagnostic tests are used for the identification of microorganisms in clinical samples and the detection of autoimmune diseases. In the Genomics area, the focus is on the development and sale of PCR kits for genotyping single nucleotide polymorphisms (SNPs) and analysis kits for RNA expression. These solutions allow for the identification and validation of genes in specific biological samples in a way that improves customers' understanding and enables accurate findings. IntegraGen SA is committed to continuously developing new tests and platforms to help its customers achieve more precise diagnoses and better therapies. One notable development of the company is the screening kit "Arisk," which is specifically designed for identifying genotypes that have an increased risk of colorectal cancer. The screening kit uses specific SNPs to ensure that doctors can identify patients who require increased monitoring or even prophylactic surgery. The use of genomics technology and biomarker-based diagnostics is a growing trend in medicine. IntegraGen SA plays a significant role in enabling the integration of genomics into clinical practice, ensuring the best possible diagnosis and treatment for patients. In summary, IntegraGen SA is an innovative biotechnology company dedicated to providing solutions for the diagnosis and prevention of diseases using various technologies. The company is constantly striving to develop new products and services to provide customers and partners with the best possible diagnostic and therapeutic support. Integragen ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Integragen's P/E Ratio
The Price to Earnings (P/E) Ratio of Integragen is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Integragen's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Integragen is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Integragen’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Integragen stock
How has the price-earnings ratio of Integragen changed compared to last year?
The price-to-earnings ratio of Integragen has increased by -100.23% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Integragen high compared to other companies?
Yes, the price-to-earnings ratio of Integragen is high compared to other companies.
How does an increase in the price-earnings ratio of Integragen affect the company?
An increase in the price-earnings ratio of Integragen would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Integragen affect the company?
A decrease in the price-earnings ratio of Integragen would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Integragen?
Some factors that influence the price-earnings ratio of Integragen are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Integragen pay?
Over the past 12 months, Integragen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Integragen is expected to pay a dividend of 0 EUR.
What is the dividend yield of Integragen?
The current dividend yield of Integragen is .
When does Integragen pay dividends?
Integragen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Integragen?
Integragen paid dividends every year for the past 0 years.
What is the dividend of Integragen?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Integragen located?
Integragen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Integragen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Integragen from 1/6/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 1/6/2025.
When did Integragen pay the last dividend?
The last dividend was paid out on 1/6/2025.
What was the dividend of Integragen in the year 2024?
In the year 2024, Integragen distributed 0 EUR as dividends.
In which currency does Integragen pay out the dividend?
The dividends of Integragen are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Integragen
Our stock analysis for Integragen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integragen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
